N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate

C98H120N26O9 — CID 157089424

IUPACN-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate
SMILESCC(=O)CCC(=O)NCC(C)(C)n1nc(-c2ccc(C)cc2)c2c(N)ncnc21.COCCC(=O)NCC(C)(C)n1nc(-c2ccc(C)cc2)c2c(N)ncnc21.Cc1ccc(-c2nn(C(C)(C)CNC(=O)CCCCCNC(=O)OCc3ccccc3)c3ncnc(N)c23)cc1.Cc1ccc(-c2nn(C(C)(C)CNC(=O)c3cccc(N4CCOCC4)c3)c3ncnc(N)c23)cc1
InChIInChI=1S/C30H37N7O3.C27H31N7O2.C21H26N6O2.C20H26N6O2/c1-21-13-15-23(16-14-21)26-25-27(31)34-20-35-28(25)37(36-26)30(2,3)19-33-24(38)12-8-5-9-17-32-29(39)40-18-22-10-6-4-7-11-22;1-18-7-9-19(10-8-18)23-22-24(28)30-17-31-25(22)34(32-23)27(2,3)16-29-26(35)20-5-4-6-21(15-20)33-11-13-36-14-12-33;1-13-5-8-15(9-6-13)18-17-19(22)24-12-25-20(17)27(26-18)21(3,4)11-23-16(29)10-7-14(2)28;1-13-5-7-14(8-6-13)17-16-18(21)23-12-24-19(16)26(25-17)20(2,3)11-22-15(27)9-10-28-4/h4,6-7,10-11,13-16,20H,5,8-9,12,17-19H2,1-3H3,(H,32,39)(H,33,38)(H2,31,34,35);4-10,15,17H,11-14,16H2,1-3H3,(H,29,35)(H2,28,30,31);5-6,8-9,12H,7,10-11H2,1-4H3,(H,23,29)(H2,22,24,25);5-8,12H,9-11H2,1-4H3,(H,22,27)(H2,21,23,24)
InChIKeyAEMHHGOYOBLOTP-UHFFFAOYSA-N
MW1806.21 g/mol
LogP12.98
Rot. Bonds32

About N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate

N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate (PubChem CID 157089424) has the molecular formula C98H120N26O9 and a molecular weight of 1806.21 g/mol. Its IUPAC name is N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate.

Molecular Properties

Compound NameN-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate
PubChem CID157089424
Molecular FormulaC98H120N26O9
Molecular Weight1806.21 g/mol
Exact Mass1804.97
IUPAC NameN-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate
SMILESCC(=O)CCC(=O)NCC(C)(C)n1nc(-c2ccc(C)cc2)c2c(N)ncnc21.COCCC(=O)NCC(C)(C)n1nc(-c2ccc(C)cc2)c2c(N)ncnc21.Cc1ccc(-c2nn(C(C)(C)CNC(=O)CCCCCNC(=O)OCc3ccccc3)c3ncnc(N)c23)cc1.Cc1ccc(-c2nn(C(C)(C)CNC(=O)c3cccc(N4CCOCC4)c3)c3ncnc(N)c23)cc1
InChIInChI=1S/C30H37N7O3.C27H31N7O2.C21H26N6O2.C20H26N6O2/c1-21-13-15-23(16-14-21)26-25-27(31)34-20-35-28(25)37(36-26)30(2,3)19-33-24(38)12-8-5-9-17-32-29(39)40-18-22-10-6-4-7-11-22;1-18-7-9-19(10-8-18)23-22-24(28)30-17-31-25(22)34(32-23)27(2,3)16-29-26(35)20-5-4-6-21(15-20)33-11-13-36-14-12-33;1-13-5-8-15(9-6-13)18-17-19(22)24-12-25-20(17)27(26-18)21(3,4)11-23-16(29)10-7-14(2)28;1-13-5-7-14(8-6-13)17-16-18(21)23-12-24-19(16)26(25-17)20(2,3)11-22-15(27)9-10-28-4/h4,6-7,10-11,13-16,20H,5,8-9,12,17-19H2,1-3H3,(H,32,39)(H,33,38)(H2,31,34,35);4-10,15,17H,11-14,16H2,1-3H3,(H,29,35)(H2,28,30,31);5-6,8-9,12H,7,10-11H2,1-4H3,(H,23,29)(H2,22,24,25);5-8,12H,9-11H2,1-4H3,(H,22,27)(H2,21,23,24)
InChIKeyAEMHHGOYOBLOTP-UHFFFAOYSA-N
XLogP12.98
TPSA471.98 Ų
H-Bond Donors9
H-Bond Acceptors30
Rotatable Bonds32
Heavy Atoms133
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001806.21
LogP ≤ 512.98
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1030

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

6-amino-N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]hexanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-(morpholin-4-ylmethyl)pyridine-2-carboxamide;tert-butyl N-[4-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-4-oxobutyl]carbamate;tert-butyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate;2,2,2-trifluoroacetaldehyde
CID 158515356
5-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-5-methylhexan-2-one;5-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-1,1,1-trifluoro-5-methylhexan-2-one;benzyl N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]carbamate;1-[1-(bromoamino)-2-methylpropan-2-yl]-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine;1-[1-(dimethylamino)-2-methylpropan-2-yl]-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine
CID 161119799
N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-piperidin-1-ylbenzamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate
CID 157482801
N-[2-[4-amino-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]benzamide;N-[2-[4-amino-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]pyridine-2-carboxamide;benzyl N-[2-[4-amino-3-(4-chlorophenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]carbamate;3-(4-chlorophenyl)-1-(2-methylbutan-2-yl)pyrazolo[3,4-d]pyrimidin-4-amine
CID 157623476
N'-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]benzenecarboximidamide;N'-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]pyridine-2-carboximidamide;benzyl N-[2-[4-amino-3-[(3-methylphenyl)methyl]pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]carbamate;1-[1-(4,5-dihydro-1H-imidazol-2-ylamino)-2-methylpropan-2-yl]-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine
CID 158070148
bis(5-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-5-methylhexan-2-one);benzyl N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]carbamate;1-[1-(bromoamino)-2-methylpropan-2-yl]-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine;1-[1-(dimethylamino)-2-methylpropan-2-yl]-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-4-amine
CID 158357243
3-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]propan-1-ol;1-[4-(cyclohexylamino)-1H-pyrazolo[4,3-c]pyridin-3-yl]pyrrolidin-2-one;N-cyclohexyl-3-[1-(2-morpholin-4-ylethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;N-cyclohexyl-3-[1-(pyridin-2-ylmethyl)pyrazol-4-yl]-1H-pyrazolo[4,3-c]pyridin-4-amine;methyl 4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]benzoate
CID 158684821
CID 158929785
CID 158929785
6-[3-[[butyl(methyl)amino]methyl]phenyl]-N-(oxan-4-yl)-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;tert-butyl N-methyl-N-[2-[methyl-[[3-[4-(oxan-4-ylcarbamoyl)-1-propan-2-ylpyrazolo[5,4-b]pyridin-6-yl]phenyl]methyl]amino]ethyl]carbamate;6-[3-[[methyl-[2-(methylamino)ethyl]amino]methyl]phenyl]-N-(oxan-4-yl)-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxamide;6-[3-[[methyl-[2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]ethyl]amino]methyl]phenyl]-1-propan-2-ylpyrazolo[5,4-b]pyridine-4-carboxylic acid;oxan-4-amine
CID 159147772
3-(2-acetamidoethoxy)-N-[2-[3-[4-[(6-amino-2-methyl-8-oxo-7H-purin-9-yl)methyl]phenyl]pyrazol-1-yl]ethyl]-N-cyclobutylpropanamide;[4-[(3S)-3-[[(2S)-6-(2-acetamidoethoxy)-4-oxo-2-propan-2-ylhexanoyl]amino]-6-(carbamoylamino)-2-oxohexyl]phenyl]methyl N-[2-[3-[4-[(6-amino-2-methyl-8-oxo-7H-purin-9-yl)methyl]phenyl]pyrazol-1-yl]ethyl]-N-cyclobutylcarbamate
CID 159298181
1-[4-[2-(aminomethyl)morpholin-4-yl]-9H-pyrimido[4,5-b]indol-7-yl]ethanone;methyl 4-[2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]morpholin-4-yl]-9H-pyrimido[4,5-b]indole-7-carboxylate;N'-(7-methyl-9H-pyrimido[4,5-b]indol-4-yl)ethane-1,2-diamine;[4-(7-methyl-9H-pyrimido[4,5-b]indol-4-yl)morpholin-2-yl]methanamine;1-(7-methyl-9H-pyrimido[4,5-b]indol-4-yl)piperidin-4-amine;[1-(7-methyl-9H-pyrimido[4,5-b]indol-4-yl)piperidin-4-yl]methanamine;N'-(7-methyl-9H-pyrimido[4,5-b]indol-4-yl)propane-1,3-diamine
CID 159319857
Ethyl 4-(4-morpholin-4-ylphenyl)-1-(1-phenylmethoxycarbonylpyrrolidin-3-yl)-3-propan-2-ylpyrazolo[5,4-b]pyridine-6-carboxylate;ethyl 4-(4-morpholin-4-ylphenyl)-3-propan-2-yl-1-pyrrolidin-3-ylpyrazolo[5,4-b]pyridine-6-carboxylate
CID 159852873

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate?
The IUPAC name of N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate (CID 157089424) is N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate.
What is the SMILES notation for N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate?
The canonical SMILES for N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate is CC(=O)CCC(=O)NCC(C)(C)n1nc(-c2ccc(C)cc2)c2c(N)ncnc21.COCCC(=O)NCC(C)(C)n1nc(-c2ccc(C)cc2)c2c(N)ncnc21.Cc1ccc(-c2nn(C(C)(C)CNC(=O)CCCCCNC(=O)OCc3ccccc3)c3ncnc(N)c23)cc1.Cc1ccc(-c2nn(C(C)(C)CNC(=O)c3cccc(N4CCOCC4)c3)c3ncnc(N)c23)cc1.
What is the InChIKey of N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate?
The InChIKey is AEMHHGOYOBLOTP-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H37N7O3.C27H31N7O2.C21H26N6O2.C20H26N6O2/c1-21-13-15-23(16-14-21)26-25-27(31)34-20-35-28(25)37(36-26)30(2,3)19-33-24(38)12-8-5-9-17-32-29(39)40-18-22-10-6-4-7-11-22;1-18-7-9-19(10-8-18)23-22-24(28)30-17-31-25(22)34(32-23)27(2,3)16-29-26(35)20-5-4-6-21(15-20)33-11-13-36-14-12-33;1-13-5-8-15(9-6-13)18-17-19(22)24-12-25-20(17)27(26-18)21(3,4)11-23-16(29)10-7-14(2)28;1-13-5-7-14(8-6-13)17-16-18(21)23-12-24-19(16)26(25-17)20(2,3)11-22-15(27)9-10-28-4/h4,6-7,10-11,13-16,20H,5,8-9,12,17-19H2,1-3H3,(H,32,39)(H,33,38)(H2,31,34,35);4-10,15,17H,11-14,16H2,1-3H3,(H,29,35)(H2,28,30,31);5-6,8-9,12H,7,10-11H2,1-4H3,(H,23,29)(H2,22,24,25);5-8,12H,9-11H2,1-4H3,(H,22,27)(H2,21,23,24).
What are the key properties of N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate?
N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate has a molecular weight of 1806.21 g/mol, XLogP of 12.98, 32 rotatable bonds, 9 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-methoxypropanamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-3-morpholin-4-ylbenzamide;N-[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]-4-oxopentanamide;benzyl N-[6-[[2-[4-amino-3-(4-methylphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-2-methylpropyl]amino]-6-oxohexyl]carbamate is sourced from PubChem (CID 157089424), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).